High-sensitivity troponin tests for the early rule out of NSTEMI

Evidence-based recommendations on high-sensitivity troponin tests for the early rule out of NSTEMI (non-ST-segment elevation myocardial infarction).

Last reviewed: 26 August 2020

Diagnostics guidance 40 has been migrated to HealthTech guidance 552. The recommendations and accompanying content remain unchanged.

This guidance replaces the NICE diagnostics guidance on myocardial infarction (acute): early rule out using high-sensitivity troponin tests (DG15).

Next review: This guideline will be reviewed if there is new evidence that is likely to change the recommendations.

Guidance development process

How we develop NICE HealthTech guidance